Mammoth Biosciences raises $45M Series B round for CRISPR diagnostics, therapeutics development
The latest round of funding, led by Chinese investors, brings the total amount of money raised by the company, co-founded by CRISPR pioneer Jennifer Doudna, to more than $70 million.